Mouse islet cell lysis mediated by interleukin-1-induced Fas

Diabetologia. 1996 Nov;39(11):1306-12. doi: 10.1007/s001250050574.

Abstract

This study was conducted to investigate the possible involvement of Fas in beta-cell death in insulitis of Type 1 (insulin-dependent) diabetes mellitus. Although primary cultured Balb/c mouse islet cells did not express Fas mRNA, 4-12 hours of treatment with 10(2)-10(3) U/l of mouse interleukin-1 alpha (IL-1 alpha) induced the expression of Fas mRNA. Surface Fas expression was detected by immunofluorescence flow cytometry using a non-cytolytic anti-Fas monoclonal antibody after 6 or 12 h of incubation with 10(3) U/l of IL-1 alpha. Primary islet cells were resistant to an agonistic anti-Fas monoclonal antibody. However, 12 h pretreatment with IL-1 alpha sensitized islet cells to its cytolytic effect. Significant cell death was observed 24 h after the addition of anti-Fas, and progressively increased until 72 h, when specific 51Cr release was 72 +/- 6%. Agarose gel electrophoresis of DNA extracted from cells exposed to IL-1 alpha and agonistic anti-Fas showed internucleosomal DNA fragmentation, a hallmark of apoptotic cell death. Since the Fas antibody showed no cross-reactive activity of tumour necrosis factor (TNF), the cytotoxic effect was not mediated by TNF receptors. A protein synthesis inhibitor cycloheximide augmented Fas-mediated islet cell death. The Fas-mediated killing of islet cells was not L-arginine-dependent, or blocked by N(G)-monomethyl-L-arginine. beta-TC1 cells also expressed Fas mRNA when exposed to IL-1 alpha or IL-1 alpha plus interferon-gamma. These observations suggest that Fas-mediated apoptosis may be a mechanism of islet cell death in autoimmune insulitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Autoimmune Diseases / etiology
  • Autoimmune Diseases / immunology
  • Cells, Cultured
  • Chromates / analysis
  • Chromates / metabolism
  • Chromium Radioisotopes
  • Cycloheximide / pharmacology
  • Cytotoxicity, Immunologic / drug effects
  • Cytotoxicity, Immunologic / immunology*
  • Diabetes Mellitus, Type 1 / etiology
  • Diabetes Mellitus, Type 1 / immunology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Gene Expression Regulation / immunology*
  • Interleukin-1 / pharmacology*
  • Islets of Langerhans / cytology
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / immunology
  • Islets of Langerhans / metabolism*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Polymerase Chain Reaction
  • Protein Synthesis Inhibitors / pharmacology
  • RNA, Messenger / analysis
  • RNA, Messenger / genetics
  • Rats
  • Sodium Compounds / analysis
  • Sodium Compounds / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology
  • fas Receptor / biosynthesis*
  • fas Receptor / drug effects
  • fas Receptor / genetics
  • fas Receptor / immunology
  • omega-N-Methylarginine / pharmacology

Substances

  • Antibodies, Monoclonal
  • Chromates
  • Chromium Radioisotopes
  • Enzyme Inhibitors
  • Interleukin-1
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • Sodium Compounds
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • omega-N-Methylarginine
  • sodium chromate(VI)
  • Cycloheximide